Portoenterostomy (PE) has remained as the generally accepted first line surgical treatment
for biliary atresia (BA) for over 50 years. Currently, close to half of BA patients survive …

Several patient and treatment related factors significantly modify outcomes of biliary atresia.
The extremely variable prognosis mandates intensive postoperative monitoring following …

Purpose We aimed to assess the dynamic changing trend of serum matrix metalloproteinase-
7 (MMP-7) in biliary atresia (BA) patients from diagnosis to LTx to further elucidate its clinical …

Abstract Purpose Cholangitis after Kasai procedure has been previously shown to be
related to poor prognosis in Biliary Atresia (BA). To investigate the risk factors and clinical …

Objectives Kasai portoenterostomy (KPE) is the treatment of choice for the fatal devastating
infantile type III biliary atresia (BA). The study aimed to analyze short-and long-term …

Biliary atresia, a fibro-obliterative disease of the newborn, is usually initially treated by Kasai
portoenterostomy, although there are many variations in technique and different options for …

Background Fibroblast growth factor 19 (FGF19) is produced in the small intestine and is
involved in suppression of hepatic bile acid (BA) synthesis. FGF19 is also expressed in the …

Background: Biliary atresia's (BA) response to surgical Kasai portoenterostomy (KP) is
uneven and dependent upon bile flow; 50% of infants require a liver transplant by 24 …

Objective To evaluate the feasibility of ultrasound shear wave elastography (SWE) for
predicting hepatic fibrosis and native liver outcomes in patients with biliary atresia. Materials …

Background Biliary atresia (BA) is a severe neonatal disease with progressive intra-and
extra-hepatic bile ducts inflammation and hepatic fibrosis. Characterization of gut …